# Orbits Oncology

> AI-powered intelligence platform for complex in-vitro models — organoids, spheroids, and organs-on-chip — for drug discovery and precision medicine. Turn complex 3D imaging and phenotypic data into actionable insights.

Orbits Oncology combines live, human-relevant in-vitro models (patient-derived tumor organoids, spheroids, and organ-on-chip / microphysiological systems) with artificial intelligence to help researchers discover better drugs and help clinicians choose the right treatment for each patient. The platform extracts quantitative, biologically meaningful features from 3D imaging data and applies machine-learning models to predict drug response, rank therapies, and characterize tumor behavior across complex in-vitro models.

## Pages

- [Platform](/): Overview of the Orbits intelligence platform — AI-powered analysis of organoids, spheroids, and organs-on-chip, drug discovery workflows, and precision medicine applications.
- [Science](/science): Peer-reviewed publications and preprints underlying the Orbits platform, including organoid, spheroid, and organ-on-chip screening, NOGR metrics, and image-derived response measurements.
- [Team](/team): The Orbits Oncology leadership team — scientists, engineers, and entrepreneurs advancing AI intelligence across complex in-vitro models for cancer research and patient care.